세계 합성생물학 시장 규모는 2023년 154억 달러, 2024년 193억 달러에서 예측 기간 동안 26.1%의 연평균 복합 성장률(CAGR)을 나타내고, 2029년 말에는 616억 달러 규모에 달할 것으로 예상됩니다.
인에이블드 제품 부문은 2024년 101억 달러에서 연평균 28.0% 성장하여 2029년 말에는 348억 달러에 이를 것으로 예상됩니다. 또한, 인에이블링 제품 부문은 2024년 68억 달러에서 연평균 25.1% 성장하여 2029년 말에는 210억 달러에 달할 것으로 예상됩니다.
세계 합성생물학(Synthetic Biology) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
밸류체인 분석
규제 프레임워크
미국 GEM 규제
합성생물학이 생물 다양성 보전에 미치는 영향
직접적인 영향
간접적인 영향
제3장 시장 역학
개요
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
제4장 새로운 동향과 특허 분석
새로운 동향
CRISPR-Cas 시스템
유전자 드라이브
확장 유전 코드
광유전체학
합성 유전체학
무세포 시스템
마이크로바이옴 공학
특허 분석
주요 부여 특허
특허 리뷰
제5장 시장 세분화 분석
세분화 내역
시장 분석 : 제품 유형별
Enabled Products
구현 제품
생물학적 성분
통합 시스템
시장 분석 : 최종사용자별
Enabled Products : 최종사용자별
구현 제품 최종사용자별
생물학적 성분 : 최종사용자별
통합 시스템 : 최종사용자별
지역 분석
시장 분석 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
기업 점유율 분석
산업에 대한 투자
제7장 합성생물학 시장 지속가능성 : ESG 관점
개요
바이오테크놀러지 업계 ESG 동향
ESG 리스크와 과제
ESG 시점
환경에 대한 영향
사회적 영향
거버넌스와 윤리적 배려
제8장 부록
조사 방법
출전
두자어
기업 개요
AGILENT TECHNOLOGIES INC.
AMYRIS
CODEXIS INC.
EUROFINS SCIENTIFIC
GENSCRIPT
GINKGO BIOWORKS
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
TWIST BIOSCIENCE
VIRIDOS
LSH
영문 목차
영문목차
The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.
The global synthetic biology market for enabled products is projected to grow from $10.1 billion in 2024 to $34.8 billion by the end of 2029, at a CAGR of 28.0% from 2024 through 2029.
The global synthetic biology market for enabling products is projected to grow from $6.8 billion in 2024 to $21.0 billion by the end of 2029, at a CAGR of 25.1% from 2024 through 2029.
Report Scope:
The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.
Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.
BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.
By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Report Includes:
50 data tables and 45 additional tables
An analysis of the global markets for synthetic biology products and technologies
Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors
Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Value Chain Analysis
Regulatory Framework
Regulation of GEMs in the United States
Impacts of Synthetic Biology on Biodiversity Conservation
Direct Impacts
Indirect Impacts
Chapter 3 Market Dynamics
Overview
Market Drivers
Various Applications of Synthetic Biology in Diverse Fields
Increasing Funding for Research and Development
Declining Cost of DNA Sequencing
Continuous Innovations in the Synthetic Biology Field
Market Restraints
Biosafety, Biosecurity, and Ethical Issues
Market Opportunities
Increasing Demand for Fuel Alternatives
Use of Machine Learning in Synthetic Biology
Chapter 4 Emerging Trends and Patent Analysis
Emerging Trends
CRISPR-Cas Systems
Gene Drives
Expanded Genetic Code
Optogenetics
Synthetic Genomics
Cell-Free System
Microbiome Engineering
Patent Analysis
Select Patent Grants
Patent Review
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Product Type
Enabled Products
Enabling Products
Biologic Components
Integrated Systems
Market Analysis, by End User
Enabled Product, by End User
Enabling Product, by End User
Biologic Components, by End User
Integrated Systems, by End User
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Company Share Analysis
Investment in Industry
Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective
